Best evaluated regarding the genetic makeup of human essential hypertension is the renin-angiotensin cascade, which has drawn special attention for its pivotal role in the homoeostasis of circulatory system. The major biologically active product of this cascade is angiotensin II, which is an important effector on electrolyte balance and vascular remodeling mainly by interacting with angiotensin II type 1 receptor (AT 1 R).
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The human AT 1 R gene (gene: AT 1 R; protein: AT 1 R) consists of five exons and spans over 55 kb on chromosome 3q21-25. A series of biological and clinical studies have implicated AT 1 R as a logical candidate for involvement in the underlying cause of hypertension. The AT 1 R antagonists were shown to be effective anti-hypertensive agents. 2 A genomewide scan suggested that the AT 1 R variation was the most significant contributor to hypertension in Finnish populations. 3 So far, of more than 50 polymorphisms in AT 1 R, 1 transversion polymorphism (A1166C) in 3 0 -untranslated region ranks high in relation to cardiovascular disease. 4 As this silent polymorphism does not alter a potential messenger (m)RNA polyadenylation or destabilization signal, 1 it does not seem to be functional, suggesting it may link with an unknown genetic variant in an important functional region of AT 1 R. To generate more information, we genotyped eight well-characterized promoter polymorphisms 5 of AT 1 R along with A1166C to explore the interacting information both as haplotypes and synergistically to predict essential hypertension risk in a northern Han population. As six of these polymorphisms were found to be in complete linkage (see Supplementary  Figure 2 ), analysis of four (G-2228A, C-1424G, C-521T and A1166C) should provide information for all possible haplotypes and interactions.
A hospital-based case-control study was carried out during 1998-2001 from four hospitals of Qiqihar city in Heilongjiang province. All study subjects were Northern Han Chinese. The Ethics Committee of the Qiqihar Medical College approved this study. A total of 909 subjects were enrolled in this study and provided informed consent. Thereof, 444 (48.8%) were found to have essential hypertension according to the following criteria: (1) without consanguinity at enrollment; (2) onset of hypertension aged 30-60 years; (3) systolic blood pressure (SBP) X140 mm Hg or diastolic blood pressure (DBP) X90 mm Hg; (4) free of secondary causes of hypertension through extensive clinical examination; (5) without pharmacological treatment for hypertension. The reminding 465 subjects were chosen as healthy controls based on their comparable age, gender and geography with their hypertensive counterparts. All controls had SBP and DBP less than 135 and 85 mm Hg, respectively, and had no history of cardiovascular disease.
Venous blood (5 ml) was collected and heparinized. Genomic DNA was extracted using the salt phenol/chloroform method. Genotyping was determined by PCR-restriction-fragment length polymorphism and PCR-single-strand conformation polymorphism techniques. The primers and conditions for the eight promoter polymorphisms and A1166C were according to reports of Erdmann et al. 5 and Zhang et al., 6 respectively. PCR amplification was carried out in a PTC-200 MJ Research Peltier Thermal Cycler (Bio-Rad Laboratories, Watertown, MA, USA).
The w 2 -test was run to assess the goodness-of-fit of Hardy-Weinberg proportions in each group and evaluate the genotype differences between case-control groups using SAS 9.1.3 (SAS Institute Inc., Cary, NC, USA). EH/EH þ program was employed to estimate and calculate the haplotype frequencies using w 2 -test from a series of 2 Â 2 contingency tables by combining other haplotypes. We selected the haplotype with frequency X2% in either group and used Bonferroni correction in multiple testing. Interaction analysis was implemented in the open-source multiple-drug resistance (MDR) software package (v.1.0.0) available from www.epistasis.org. Interaction dendrogram was used to visualize the nature of the dependencies.
The baseline characteristics of the study population are shown in Supplementary Table 1. There was no detectable deviation from Hardy-Weinberg equilibrium for all polymorphisms (P40.05). The A1166C genotype distribution differed remarkably between cases and controls (P ¼ 0.0006), whereas no differences were found for the others (Figure 1a) . Of the 10 different haplotypes of 4 polymorphisms harbouring G-2228A, C-1424G, C-521T and A1166C in order, haplotypes G-G-C-A and A-C-T-A had an increased risk for essential hypertension, whereas haplotypes G-C-C-C and A-G-C-C had a reduced risk after the Bonferroni correction (Po0.05/16; Figure 1b) . Figure 1c summarizes the interaction information analysis. Shown was an interaction dendrogram highlighting the amount of information gained about case-control status by putting two polymorphisms together using the MDR function. Polymorphisms G-2228A and C-1424G, connected with a red line, had a strong synergistic interaction, the other two polymorphisms with a yellow line had an additive effect, and the joint effect of these two sets was mostly additive (Figure 1c, left) . The pattern of high-risk (dark grey) and low-risk (light grey) genotype combinations was non-linear across the nine two-locus genotype cells (Figure 1c, right) , which represents interaction as suggested by the interaction analysis.
Usually, the combined effects of the two or more genes/loci on disease status cannot be accurately described as the sum of their separate effects, but only within a framework that accommodates epistasis, a phenomenon whereby the effects of a given gene/ locus on a biological trait are masked or potentiated by one or more other genes/loci. 7 In current study we found strong evidence for interaction between polymorphisms G-2228A and C-1424G that were apparently unassociated with essential hypertension in single-locus analysis. Indirectly, we can extend this interaction to five additional polymorphisms that are completely linked with G-2228A that we tested.
Our single-locus results indicated significant association of A1166C variant with essential hypertension, which was consistent with some reports. 8, 9 The silent nature of A1166C necessitates the exploration of linkage pattern with another functional variant(s) in AT 1 R. It has been reported that A1166C linked weakly but significantly with promoter variant T-810A, suggesting the slight association of A1166C with AT 1 R expression, 5 although unfortunately in this study no linkage was observed between A1166C and the promoter variants (see Supplementary Figure 2 ) in line with some previous reports. 6, 10 Our interaction analysis indicated that the contribution of A1166C to disease risk might be independent of or additive to other variants investigated.
As we previously indicated, haplotype analysis could provide more information about the effect of genetic interaction, especially when these alleles have a synergistic effect.
11
In this study, we identified two risk-conferring haplotypes (in order of G-2228A, C-1424G, C-521T and A1166C) G-G-C-A and A-C-T-A for and two risk-reducing haplotypes G-C-C-C and A-G-C-C against essential hypertension. Two possible inferences can be drawn here. One is the action of a certain allele played a leading role, such as '1166A' allele harbouring the riskconferring haploytpes and '1166C' allele harbouring the risk-reducing ones. Another inference is the epistasis framework between G-2228A and C-1424G because haplotype with only one mutant allele (G-G and A-C) of the two variants has an increased risk, whereas haplotype with two wild or mutant alleles has a reduced risk for essential hypertension. We thus reasoned that the two co-existent mutations might offset each other in the course of the disease. This might indicate the existence of interaction. Furthermore, Plumb et al.
12 showed that T-810A mutation destroys a transcriptional factor-binding site for GATA-binding factors, which leads to the speculation that T-810A might interact with C-1424G to regulate transcriptional level of AT 1 R upon susceptibility to essential hypertension. However, because of the complexity of interaction information, the jury must remain out until a larger, well-designed study confirms or refutes these findings.
In sum, we demonstrate the interacting effect of AT 1 R variants upon susceptibility to essential hypertension in Northern Han Chinese. Further studies are warranted to evaluate the functional consequences of these variants.
